Nexus Company Profile

What is the competitive landscape for NEXUS

NEXUS has twenty-four approved drugs.

There are five US patents protecting NEXUS drugs. There is one tentative approval on NEXUS drugs.

Summary for Nexus

US Patents:	5
Tradenames:	26
Ingredients:	23
NDAs:	24
Patent Litigation for Nexus:	See patent lawsuits for Nexus
PTAB Cases with Nexus as petitioner:	See PTAB cases with Nexus as petitioner

Drugs and US Patents for Nexus

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Nexus	SODIUM CHLORIDE 0.9%	sodium chloride	SOLUTION;INJECTION	217535-001	Aug 23, 2023	AP	RX	No	No
Nexus	EMERPHED	ephedrine sulfate	SOLUTION;INTRAVENOUS	213407-002	Feb 28, 2023		RX	Yes	Yes	11,464,752		Y
Nexus	PROCAINAMIDE HYDROCHLORIDE	procainamide hydrochloride	INJECTABLE;INJECTION	206332-001	Oct 13, 2017	AP	RX	No	No
Nexus	EMERPHED	ephedrine sulfate	SOLUTION;INTRAVENOUS	213407-001	Apr 17, 2020	AP1	RX	Yes	Yes	11,478,436
Nexus	TACROLIMUS	tacrolimus	INJECTABLE;INJECTION	217108-001	Feb 12, 2025	AP	RX	No	No
Nexus	POTASSIUM CHLORIDE	potassium chloride	INJECTABLE;INJECTION	217704-001	Aug 14, 2023	AP	RX	No	No
Nexus	POTASSIUM CHLORIDE 20MEQ	potassium chloride	INJECTABLE;INJECTION	214727-004	Mar 18, 2021	AP	RX	No	No

International Patents for Nexus Drugs

Country	Patent Number	Estimated Expiration
Mexico	2021013888
Japan	2022532657
South Korea	102675027
Canada	3140043
World Intellectual Property Organization (WIPO)	2020232424
European Patent Office	3968975
Japan	2023091072

Supplementary Protection Certificates for Nexus Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
3347352	2290051-8	Sweden		PRODUCT NAME: LENACAPAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR LENACAPAVIR SODIUM; REG. NO/DATE: EU/1/22/1671 20220819
0294114	2007C/063	Belgium		PRODUCT NAME: NELARABINE; REGISTRATION NO/DATE: EU/1/07/403/001 20070823
0478363	2000C/002	Belgium		PRODUCT NAME: TIROFIBANUM HYDROCHLORIDUM (EQ. TIROFIBAN); NAT. REGISTRATION NO/DATE: 922 IS 191 F 12 19990906; FIRST REGISTRATION: CH 54761 19980528
1948158	93075	Luxembourg		PRODUCT NAME: SACUBITRIL ET VALSARTAN, SOUS FORME DE COMPLEXE SODIQUE SACUBITRIL VALSARTAN, C'EST-A-DIRE DE (3-((1S,3R)-1-BIPHENYL-4-YLMETHYL-3-ETHOXYCARBONYL-1-BUTYLCARBAMOYL)PROPIONATE-(S)-3'-METHYL-2-(PENTANYOL(2''-(TETRAZOL-5-YLATE)BIPHENYL-4'-YLMETHYL)AMINO)BUTYRATE) DE TRISODIUM HEMIPENTAHYDRATE; AUTHORISATION NUMBER AND DATE: EU/1/15/1058 20151123
1874117	2014/032	Ireland		PRODUCT NAME: DOLUTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, INCLUDING DOLUTEGRAVIR SODIUM; REGISTRATION NO/DATE: EU/1/13/892/001-002 20140121
2380576	20C1048	France		PRODUCT NAME: SEL DE SODIUM DE L'ACIDE DESOXYCHOLIQUE; NAT. REGISTRATION NO/DATE: NL46299 20180810; FIRST REGISTRATION: IS - IS/1/16/071/01 20160729
2822954	18C1035	France		PRODUCT NAME: BICTEGRAVIR OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,EN PARTICULIER BICTEGRAVIR DE SODIUM; REGISTRATION NO/DATE: EU/1/18/1289 20180625

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Nexus